​

Funding Round

Venture Round - Exagen

Venture Round - Exagen

Investment Firm

Overview

Exagen is a patient focused, discovery-driven life science company serving patients affected by autoimmune rheumatic diseases.

Announced Date

Jul 16, 2019

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners is a debt and early_stage_venture and late_stage_venture and venture firm.

Participant Investors

4

Investor Name
Participant InvestorSun Mountain Capital
Participant InvestorJ. Hunt Holdings
Participant InvestorTullis Health Investors
Participant InvestorH.I.G. BioHealth Partners

Round Details and Background

Exagen raised $22600000 on 2019-07-16 in Venture Round

Exagen is a patient focused, discovery-driven life science company serving patients affected by autoimmune rheumatic diseases.

Company Funding History

24

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 19, 2011
Venture Round - Exagen
3-12.0M
Nov 02, 2012
Debt Financing - Exagen
-123.7K
Sep 10, 2012
Series C - Exagen
5-5.3M
Jun 28, 2005
Series B - Exagen
3-7.0M

Recent Activity

There is no recent news or activity for this profile.